In sensitivity analyses, we re-ran the main models adjusting for common non-AD pathologies, such as cerebral amyloid angiopathy, Lewy body pathology, TDP-43, hippocampal sclerosis, and vascular pathology. This evidence concerns the gene TARDBP and cerebral amyloid angiopathy.